Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q2 2020 · 10-Q
Revenue$5.13M$5.13M+217.8% vs Q2 2019 Net Income$1.12M$1.12MN/M vs Q2 2019 EPS Diluted$0.04$0.04N/M vs Q2 2019 Operating Income$1,651,597+346.0% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,012,078N/M Margins · derivedOperating margin32.2%+9.3 pt vs Q2 2019
Net margin21.9%+32.3 pt vs Q2 2019
ended Jun 30, 2020 · filed Nov 18, 2020 · 141 d after period end